Triamcinolone acetonide intralesional injection for the treatment of keloid scars: patient selection and perspectives

Figures & data

Table 1 Dose of TAC used by different authors when using TAC in monotherapy and in combination therapy

Study	TAC dose and/or concentration	Associated treatment	Number of injections	Interval between sessions (weeks)
Rahban and Garner^Citation26	10 mg/mL	–	2–3	4–8
Darzi et al^Citation27	10–20 mg/cm^2	–	4	–
Robles et al^Citation9	10–40 mg/mL	–	Multiple	4
Acosta et al^Citation28	4–40 mg/mL	–	1–5	4
Ahuja and Chatterjee^Citation37	40 mg/mL	–	Maximum 8	3
Danielsen et al^Citation38	1 mg/cm (maximum 5 mg)	Surgical excision (before TAC injection)	4	4
Kant et al^Citation39	2–4 mg of TAC 40 mg/mL	0.05–0.1 mL of verapamil 2.5 mg/mL	3	Second injection after 1 week, third injection 3 weeks later
Saha and Mukhopadhyay^Citation43	40 mg/mL	–	Maximum 6	1
Fitzpatrick^Citation45	1 mg	5-FU 45 mg	5–10	–
Khan et al^Citation46	4 mg	5-FU 45 mg	8	1
Tan et al^Citation71	40 mg/mL	–	–	4
Kassab and El Kharbotly^Citation63	40 mg/mL	980 nm diode laser	2–5	–
Payapvipapong et al^Citation77	10 mg/mL	–	3	4

Abbreviations: 5-FU, 5-fluorouracil; TAC, triamcinolone acetonide.

MuneuchiGSuzukiSOnoderaMItoOHataYIgawaHHLong-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patientsScand J Plast Reconstr Surg Hand Surg200640211111616537259

 PubMed Web of Science ®Google Scholar

RahbanSGarnerWFibroproliferative scarsClin Plast Surg2003301778912636218

 PubMed Web of Science ®Google Scholar

RoblesDTMooreEDrazninMBergDKeloids: pathophysiology and managementDermatol Online J20071339

 PubMedGoogle Scholar

DarziMAChowdriNAKaulSKKhanMEvaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up studyBr J Plast Surg1992453743791638291

 PubMedGoogle Scholar

BoggioRFFreitasVMCassiolaFMUrabayashiMMachado-SantelliGMEffect of a calcium-channel blocker (verapamil) on the morphology, cytoskeleton and collagenase activity of human skin fibroblastsBurns201137461662520800972

 PubMed Web of Science ®Google Scholar

AhujaRBChatterjeePComparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloidsBurns201440458358824182692

 PubMed Web of Science ®Google Scholar

DanielsenPLReaSMWoodFMVerapamil is less effective than triamcinolone for prevention of keloid scar recurrence after excision in a randomized controlled trialActa Derm Venereol201696677477826911400

 PubMed Web of Science ®Google Scholar

WendlingJMarchandAMauvielAVerrecchiaF5-Fluorouracil blocks transforming growth factor-beta-induced alpha 2 type I collagen gene (COL1A2) expression in human fibroblasts via c-Jun NH2-terminal kinase⁄activator protein-1 activationMol Pharmacol200364370771312920208

 PubMed Web of Science ®Google Scholar

SadeghiniaASadeghiniaSComparison of the efficacy of intralesional triamcinolone acetonide and 5 fluorouracil tattooing for the treatment of keloidsDermatol Surg201238110410922093096

 PubMed Web of Science ®Google Scholar

FitzpatrickRETreatment of inflamed hypertrophic scars using intralesional 5-FUDermatol Surg199925322423210193972

 PubMed Web of Science ®Google Scholar

KatzBESilicone gel sheeting in scar therapyCutis199556165677555106

 PubMed Web of Science ®Google Scholar

RossiALuRFreyMKKubotaTSmithLAPerezMThe use of the 300 microsecond 1064 nm Nd:YAG laser in the treatment of keloidsJ Drugs Dermatol201312111256126224196333

 PubMed Web of Science ®Google Scholar

BodokhIBrunPTreatment of keloid with intralesional bleomycin (French)Ann Dermatol Venereol1996123127917949636763

 PubMed Web of Science ®Google Scholar